UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041038
Receipt number R000043832
Scientific Title Examination of the feeling of taking for improvement of medication adherence of clarithromycin dry syrup in pediatric patients
Date of disclosure of the study information 2020/07/09
Last modified on 2020/07/09 09:43:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of the feeling of taking for improvement of medication adherence of clarithromycin dry syrup in pediatric patients

Acronym

Examination of the feeling of taking for improvement of medication adherence of clarithromycin dry syrup in pediatric patients

Scientific Title

Examination of the feeling of taking for improvement of medication adherence of clarithromycin dry syrup in pediatric patients

Scientific Title:Acronym

Examination of the feeling of taking for improvement of medication adherence of clarithromycin dry syrup in pediatric patients

Region

Japan


Condition

Condition

Respiratory disease

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the feeling of taking antibiotics of generic and generic products in pediatric patients and investigate the effect on medication adherence.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Medication adherence

Key secondary outcomes

Feeling of taking (ease of drinking, facial expression, ease of melting, smell, sweetness, bitterness)


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

A simple randomized cross-over study was conducted using two drugs, one that had been adopted in the past (brand name A) and the other that had been adopted after the taste test (brand name B), and each drug was taken twice a day for two days.

Interventions/Control_2

At the end of each dose, sweetness, bitterness, odor, solubility (index I-IV), and ease of taking the drug were assessed in five levels, and ease of taking were analyzed by multiple regression analysis with ease of taking as the objective variable.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

3 years-old <=

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients 3 years of age or older who were seen in our pediatric outpatient clinic between April 1, 2018 and March 31, 2020, and for whom CAM-DS was prescribed and who are considered to have a taste complaint.

Key exclusion criteria

Patients who are unable to take their medication or for whom parental consent could not be obtained

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Tomona
Middle name
Last name Sogo

Organization

Mitoyo General Hospital

Division name

Pharmaceutical department

Zip code

769-1695

Address

708 Himehama,Toyohama-cho,Kan-onji-city,Kagawa,JAPAN

TEL

0875-52-3366

Email

shino-ph@mitoyo-hosp.jp


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name Shinonaga

Organization

Mitoyo General Hospital

Division name

Pharmaceutical department

Zip code

769-1695

Address

708 Himehama,Toyohama-cho,Kan-onji-city,Kagawa,JAPAN

TEL

0875-52-3366

Homepage URL


Email

shino-ph@mitoyo-hosp.jp


Sponsor or person

Institute

Mitoyo General Hospital
Pharmaceutical department

Institute

Department

Personal name



Funding Source

Organization

Mitoyo General Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Review Committee of Mitoyo General Hospital

Address

708 Himehama,Toyohama-cho,Kan-onji-city,Kagawa,JAPAN

Tel

0875-52-3366

Email

shino-ph@mitoyo-hosp.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

17CR01-057

Org. issuing International ID_1

Clinical Research Review Committee of Mitoyo General Hospital

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

三豊総合病院(香川県)


Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

19

Results

The mean dosing status score for brand name A was 18.1 and for generic B was 19.3. Multiple regression analysis revealed that the standard regression coefficients for the original drug A were I - 0.34, II 0.51, III 0.47, and IV 0. 26. (All NS) For generic B, the coefficients were I-0.07, II-1.08, III-0.42, and IV-0.28. (NS for I, p<0.01 for II and III, and p<0.05 for IV) The mean score for ease of drinking was A2 for the branded drug. .26 and generic B3.05.

Results date posted

2020 Year 07 Month 09 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 02 Month 26 Day

Date of IRB

2018 Year 02 Month 27 Day

Anticipated trial start date

2018 Year 04 Month 01 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry

2020 Year 06 Month 30 Day

Date trial data considered complete

2020 Year 06 Month 30 Day

Date analysis concluded

2020 Year 06 Month 30 Day


Other

Other related information



Management information

Registered date

2020 Year 07 Month 09 Day

Last modified on

2020 Year 07 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043832


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name